The World Health Organisation (WHO) has said that vaccination against Ebola for high-risk populations began on Monday in Côte d’Ivoire, following an outbreak in the country on Saturday.
In a statement on Tuesday, WHO stated that the swift response came after the vaccine manufactured by Merck, which WHO helped to secure to fight a four-month long outbreak in neighbouring Guinea, was quickly sent to the country.
The deployment from Guinea included 2,000 doses that were being used under the “ring strategy,” where people who have come into contact with a confirmed Ebola patient are given the vaccine, as well as first responders and health workers.
Guinea also sent around 3,000 vaccine doses manufactured by Johnson & Johnson. These are being used as booster jabs in areas not experiencing active transmission.
“The Ebola vaccine is a critical tool in the fight against the virus and so it’s a top priority to move rapidly and start protecting people at high risk of the disease, said WHO Regional Director for Africa, Dr Matshidiso Moeti.
Moeti described the quick response as “remarkable and shows that with effective sub-regional solidarity we can quickly take measures to extinguish lethal infections that can potentially flare up into large outbreaks.”
The Un Correspondent of the News Agency of Nigeria (NAN) reported from New York that the outbreak was declared in Côte d’Ivoire, after the Ebola virus was confirmed in a patient who travelled to Abidjan by road from Guinea.
One suspected case and nine contacts had also been identified and are being monitored, although no deaths have been reported.
Related Articles
There was no indication yet that the current outbreak in Côte d’Ivoire is linked to the one in Guinea and further analysis and genomic sequencing is being carried out to help determine any connection.
The outbreak is Côte d’Ivoire’s first, since 1994, and to support the country’s efforts at controlling its spread, the WHO is deploying experts to join their country-based counterparts to help ramp up infection prevention and control, diagnostics, contact tracing, treatment, community mobilisation and cross-border surveillance.
The UN agency is also assessing whether additional vaccines would be needed to curb the disease.
In Guinea, the health authorities are stepping up surveillance, carrying out further investigations, identifying contacts in readiness for vaccination and readying an Ebola treatment centre.
Since the Ebola outbreak was declared in Guinea earlier this year, WHO had been supporting six countries, including Côte d’Ivoire, to prepare for a potential outbreak.
These included support in disease surveillance, screenings at border crossing points and in high-risk communities, as well as setting up rapid response teams, improving testing and treatment capacity and reinforcing community outreach and collaboration.
The outbreak in Côte d’Ivoire is the third in 2021, after the Democratic Republic of the Congo and Guinea.
